Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of BioAtla Inc (NASDAQ: BCAB) was $0.72 for the day, up 8.04% from the previous closing price of $0.67. In other words, the price has increased by $8.04 from its previous closing price. On the day, 1.01 million shares were traded. BCAB stock price reached its highest trading level at $0.76 during the session, while it also had its lowest trading level at $0.67.
Ratios:
Our analysis of BCAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.54.
On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.JMP Securities initiated its Mkt Outperform rating on September 15, 2022, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 42565472 and an Enterprise Value of 40426472.
Stock Price History:
The Beta on a monthly basis for BCAB is 1.00, which has changed by 0.13479626 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, BCAB has reached a high of $1.43, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -7.47%, while the 200-Day Moving Average is calculated to be 35.36%.
Shares Statistics:
BCAB traded an average of 1.45M shares per day over the past three months and 1209750 shares per day over the past ten days. A total of 58.79M shares are outstanding, with a floating share count of 44.91M. Insiders hold about 23.92% of the company’s shares, while institutions hold 15.69% stake in the company. Shares short for BCAB as of 1765756800 were 4341741 with a Short Ratio of 2.99, compared to 1763078400 on 4783598. Therefore, it implies a Short% of Shares Outstanding of 4341741 and a Short% of Float of 8.37.
Earnings Estimates
The performance of BioAtla Inc (BCAB) in the stock market is under the watchful eye of 1.0 analysts actively contributing to its current rating.
Analysts are recommending an EPS of between -$1.08 and -$1.08 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.92, with 1.0 analysts recommending between -$0.92 and -$0.92.
